MJT & Associates Financial Advisory Group, Inc.
Position in AZN — Astrazeneca PLC
CIK 2065777
MONTEVICEO, MN
Position in AZN
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$12,514
New position
Shares Held
66
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,365
of 1,459 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MJT & Associates Financial Advisory Group, Inc. holds $738,071 across 12 Drug Manufacturers - General names. AZN ranks #6 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,847 | $469,082 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,700 | $97,954 | |
| 3 | MRK |
Merck & Co., Inc.
|
596 | $76,586 | |
| 4 | ABBV |
AbbVie Inc.
|
98 | $24,660 | |
| 5 | NVS |
Novartis AG
|
148 | $23,194 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
66 | $12,514 | |
| 7 | NVO |
Novo Nordisk A S
|
224 | $10,738 | |
| 8 | LLY |
ELI LILLY & Co
|
8 | $9,595 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,514 | 66 | Shares | Sole | 2026-07-06 | |
| No filing history on record for this holder in this stock. | ||||||